Hólyagrák: vizsgálatok itt: Izrael

In Izrael 20 Also abroad 625

20 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.

1. fázisTaking people
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan
Életkor
18 év and over
People
294 worldwide
Run by
Pfizer
See details and how to joinNCT07206225 · EU 2025-521756-39-00
1. fázisTaking people
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Where
Petah Tikva, Tel HaShomer
Életkor
18 év and over
People
677 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05614739 · EU 2022-502755-59-00
3. fázisTaking people
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Where
Haifa, Ramat Gan, Sderot, Tel Aviv, Yeruham
Életkor
18 év and over
People
641 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06319820
3. fázisTaking people
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Where
Haifa, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
Életkor
18 év and over
People
220 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06919965 · EU 2024-519493-39-00
3. fázisTaking people
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tsrifin
Életkor
18 év and over
People
590 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07419295 · EU 2024-520014-22-00
2. fázisTaking people
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Where
Holon, Jerusalem, Kfar Saba, Ramat Gan, Tel Aviv
Életkor
18 év and over
People
285 worldwide
Run by
Tyra Biosciences, Inc
See details and how to joinNCT07265947 · EU 2025-523539-20-00
1. fázisTaking people
Inactivated UPEC-FimON for Non Muscle Invasive Bladder Cancer After BCG or Intravesical Chemotherapy Failure
Where
Jerusalem, Kfar Saba, Ramat Gan
Életkor
18 év and over
People
30
Run by
Hopec Pharma
See details and how to joinNCT07881666
1/2. fázisTaking people
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Where
Petah Tikva
Életkor
18 év and over
People
45 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07222488 · EU 2025-520467-40-00
3. fázisTaking people
1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors
Where
Petah Tikva
Életkor
18 év and over
People
136
Run by
dmitry enikeev
See details and how to joinNCT07898033
1/2. fázisTaking people
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Where
Haifa, Petah Tikva
Életkor
18 év and over
People
55 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07232602 · EU 2025-522253-19-00
1. fázisTaking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Beersheba, Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tsrifin
Életkor
18 év and over
People
1394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
1/2. fázisTaking people
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Where
Haifa, Petah Tikva, Ramat Gan
Életkor
18 év and over
People
48 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT05562830 · EU 2023-506384-34-00
3. fázisTaking people
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Where
Haifa, Kefar Sava, Petah Tikva, Ramat Gan, Tsrifin
Életkor
18 év and over
People
70 worldwide
Run by
UroGen Pharma Ltd.
See details and how to joinNCT06774131 · EU 2024-519343-15-00
2. fázisTaking people
A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC
Where
Raanana
Életkor
18 év to 80 év
People
70
Run by
Relmada Therapeutics, Inc.
See details and how to joinNCT06663137
1/2. fázisTaking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Haifa, Petah Tikva, Ramat Gan, Tel Aviv
Életkor
18 év and over
People
1109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
2/3. fázisTaking people
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Where
Haifa, Jerusalem, Petah Tikva, Tsrifin
Életkor
18 év and over
People
470 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07106762
No phaseTaking people
LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder
Where
Haifa
Életkor
18 év and over
People
60
Run by
LifeBiotic Medical Research Ltd.
See details and how to joinNCT07728474
2. fázisTaking people
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Where
Haifa, Petah Tikva, Ramat Gan, Tel Aviv
Életkor
18 év and over
People
372 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04879329 · EU 2022-500030-28-01
1/2. fázisTaking people
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Where
Jerusalem
Életkor
18 év to 70 év
People
3
Run by
Hadassah Medical Organization
See details and how to joinNCT05296564
No phaseTaking people
POST URS Chemotherapy Instillation
Where
Ashdod, Beersheba, Be’er Ya‘aqov, Haifa, Petah Tikva, Rehovot, Safed, Tel Aviv
Életkor
18 év and over
People
264
Run by
Carmel Medical Center
See details and how to joinNCT06167057